Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Hesperos in August, 2021 for $902,320.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG071386-01A1 | Phase II | 902,320 | August 15, 2021 | |||||||
A SBIR Phase I contract was awarded to Hesperos in September, 2020 for $216,260.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44ES032360-01 | Phase I | 216,260 | September 11, 2020 | |||||||
A SBIR Phase II contract was awarded to Hesperos in March, 2021 for $754,240.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44ES032360-02 | Phase II | 754,240 | March 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Hesperos in May, 2020 for $1,483,966.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG059511-03 | Phase II | 1,483,966 | May 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Hesperos in September, 2018 for $224,946.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL140920-01 | Phase I | 224,946 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Hesperos in April, 2018 for $449,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG059511-01 | Phase I | 449,998 | April 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Hesperos in September, 2019 for $744,745.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44ES029892-02 | Phase II | 744,745 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Hesperos in September, 2018 for $220,124.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44ES029892-01 | Phase I | 220,124 | September 17, 2018 | |||||||
A SBIR Phase I contract was awarded to Hesperos in September, 2018 for $669,257.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG060886-01 | Phase I | 669,257 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Hesperos in March, 2022 for $854,765.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HL140920-02 | Phase II | 854,765 | March 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Hesperos in November, 2018 for $1,507,755.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG058330-02 | Phase II | 1,507,755 | November 15, 2018 | |||||||
A SBIR Phase I contract was awarded to Hesperos in September, 2017 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK116589-01 | Phase I | 225,000 | September 15, 2017 | |||||||
A SBIR Phase I contract was awarded to Hesperos in September, 2017 for $454,315.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG058330-01 | Phase I | 454,315 | September 15, 2017 |